Viewing Study NCT04540120


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-01-29 @ 5:15 AM
Study NCT ID: NCT04540120
Status: TERMINATED
Last Update Posted: 2023-04-13
First Post: 2020-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
Sponsor: Olatec Therapeutics LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
None Cytokine Release Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NLRP3 View
None Covid19 View
None Cytokine Release Syndrome View
None Dapansutrile View